What IQVIA's Quarter ended Sep 30, 2026 10-Q says: 4 signals
IQVIA filed its latest 10-Q with the SEC on Oct 27, 2026. It discusses bookings decline, international growth and restructuring.
Get IQVIA's live signals in Claude or ChatGPT, or by API
What changed at IQVIA this week? Use Autobound signals for iqvia.com.- Filed
- Oct 27, 2026
- Period
- Quarter ended Sep 30, 2026
- Filings
- 3
- Signals
- 21
Source: Autobound Signal API · 71 signals tracked for IQVIA · updated
10-Q · latest 10
What IQVIA's 10-Q filings say
- SEC EDGAR
10-Q · Quarter ended Sep 30, 2026
Filed · 4 signals
IQVIA reorganized business reporting into two segments effective January 1, 2026
IQVIA updated its operating model and reorganized from three segments into Commercial Solutions and Research & Development Solutions effective January 1, 2026.
IQVIA incurs $150 million in nine-month restructuring charges to streamline global operations
Restructuring costs reached $36 million in Q3 2026 and $150 million for the first nine months of 2026 as part of efforts to streamline operations, eliminate redundant positions, and integrate acquisitions.
Commercial Solutions Achieves Constant Currency Revenue Growth in Americas, Europe, Africa, and APAC
Commercial Solutions revenue grew 6.9% to $1,789 million in Q3 2026, driven by constant currency growth in the Americas, Europe and Africa, and Asia-Pacific regions.
$1.8B
Commercial Solutions revenues for Q3 2026
6.9%
increase in Commercial Solutions revenues over the same period in 2025
Research & Development Solutions backlog drops to $32.6 billion after $2.1 billion reassessment
Contracted backlog in Research & Development Solutions declined from $34.0 billion at December 31, 2025 to $32.6 billion as of September 30, 2026.
$2.1B
reduction in backlog due to refined assessment criteria on inactive trials
- SEC EDGAR
10-Q
Filed · 8 signals
IQVIA spends $950M on stock buybacks in H1 2026 under a newly expanded $2.8B authorization.
The company repurchased $950 million of its own stock in the first six months of 2026 and increased its total repurchase authorization by $2 billion.
$950M
Amount spent on stock repurchases during the six months ended June 30, 2026
IQVIA issued €950M in new senior notes in June 2026 to refinance debt.
The company completed a major debt issuance to repay a $650M term loan and pay down its revolving credit facility.
$950M
Gross proceeds from issuance of 4.625% senior notes due 2033 (in EUR millions)
U.S. Bank National AssociationU.S. Bank Trust Company, National Association
IQVIA increases H1 2026 spending on software, property, and equipment by $32M
The company increased capital expenditures on software and equipment year-over-year, signaling active investment in its technology infrastructure.
$32M
Increase in cash used for acquisitions of property, equipment and software in H1 2026 vs H1 2025
software
IQVIA's ongoing acquisition strategy drives need for post-merger system integration
IQVIA continues to evaluate and execute acquisitions, creating recurring needs for integrating disparate IT systems, data platforms, and business processes.
softwaredatabases
A $70 million decrease in cash from unearned income in the first half of 2026 suggests a slowdown in upfront customer payments for future services.
$70M
Decrease in cash from unearned income in H1 2026 vs H1 2025
- SEC EDGAR
10-Q
Filed · 9 signals
IQVIA borrowed $650M in a new term loan to repay maturing debt in March 2026.
In March 2026, IQVIA secured a new $650 million Term A loan, using the proceeds to repay €550 million in maturing senior notes.
$650M
New 364-Day Term A Loan Agreement entered into on March 11, 2026
U.S. Bank Trust Company, National Association
Showing 10 of 21 filing signals. The Signal API returns all of them.
Get them with one API callEarnings calls
IQVIA earnings headlines
From earnings call transcripts (Signal API type earnings-transcripts).
| Call date | What the company said |
|---|---|
| Announced CFO transition with successor named for early 2026.Current CFO Ron Bruehlman is retiring, to be succeeded by Mike Fedock on Feb 28, 2026. Such leadership changes, especially in finance, often lead to reviews of financial systems, reporting tools, and vendor contracts, creating opportunities for new solution providers. | |
| Actively acquiring companies, spending nearly $500M on a recent dealThe company is using acquisitions as a key growth lever, spending $485 million in total with the majority on a single R&D-focused acquisition (NEXT Oncology). This demonstrates a clear budget and appetite for M&A to expand capabilities, creating opportunities for integration and consulting services. | |
| Investing heavily in developing specialized industry AI agents to drive efficiency.IQVIA is actively developing approximately 90 specialized AI agents across 25 use cases, with a goal of 500 by early 2027. This major internal initiative signals significant investment in AI platforms, data infrastructure, and related technologies to improve margins and create new client offerings. | |
| Deploying AI to optimize global compliance reporting for pharma clients.A top 10 pharma client awarded IQVIA a contract for an AI-enabled SaaS platform to optimize global compliance reporting. This highlights a key efficiency focus for clients: reducing the cost and complexity of compliance, creating opportunities for vendors with automated reporting and regulatory technology. | |
| Investing in next-gen data management and analytics platformsThe company is winning large contracts to deploy next-generation information management, global master data management, and AI-enabled SaaS platforms for clients. This reflects a significant internal investment in their own data, analytics, and AI capabilities to deliver these advanced solutions. | |
| Aggressively targeting markets previously held by smaller, niche competitors.The 'see more, win more' strategy involves entering markets previously left to 'marginal players' who had 'quasi-monopoly' situations. This indicates an aggressive market share capture strategy, making IQVIA potentially receptive to competitive intelligence tools and solutions that provide a sales advantage. |
Signal API · MCP
Track IQVIA with the Signal API
One POST /v1/companies/enrich call with iqvia.com returns IQVIA 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"iqvia.com","signal_types":["sec-10q"],"limit":20}'Bulk data
Need this signal for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.
Same industry
Related companies
Questions about IQVIA 10-Q
When did IQVIA file its latest 10-Q?
What did IQVIA disclose in its latest 10-Q?
What did IQVIA say on its recent earnings calls?
Where can I read IQVIA's 10-Q filing?
Page updated , the date of the newest row on this page.
Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .